Summary
In an opinion article in The Hindu, former Principal Scientific Adviser K. VijayRaghavan and Archish Mittal of Iron Pillar argue that India suffers from "catch-up-itis", a habit of defining ambition by what others have already done.
They say the gap between fundamental research and application has narrowed sharply, citing how studies of bacterial immunity quickly produced CRISPR gene-editing technology, so investing in basic science now lets a country lead instead of catching up.
They propose four reforms: high-quality education at scale through AI and experimental "foundries"; opening national laboratories through green, amber and red zones; freeing proven high-performing institutions from General Financial Rules compliance and judging them by outcomes; and faster, predictable regulation for biological research and clinical trials.
They note that 10% annual improvement compounds to nearly seven times in 20 years.
WHY IN NEWS FOR UPSC & STATE PCS
K. VijayRaghavan and Archish Mittal published an opinion article in The Hindu calling for reforms to India's research ecosystem, including opening national laboratories, relaxing General Financial Rules for high-performing institutions and speeding up research regulation, so that India can lead rather than catch up in technology.
Standard News
Fix the Rules Before Adding the Money
The common diagnosis of Indian science is that it is underfunded. That is true, but it is not the main problem. India's research system is held back first by how it is administered: national laboratories closed to outsiders and procurement rules that make every purchase a compliance exercise. Until those change, more money will simply move slowly through the same channels.
Why the
administration matters more now K. VijayRaghavan and Archish Mittal make a point that changes the stakes. For much of history, technology followed science at a distance, sometimes by a century. Over roughly the last 50 years, that gap has collapsed.
Studying how bacteria defend themselves against viruses produced CRISPR, a gene-editing tool with enormous applications, within a few years. If the distance between curiosity and application is now short, then speed matters.
A country that can move from discovery to experiment to product quickly can lead. A country whose researchers wait months to procure equipment or cannot get access to a national laboratory's instruments, will keep arriving after others, paying for licences and know-how built elsewhere.
That is "catch-up-itis". Two administrative barriers stand out:
- Closed national laboratories. Most are poorly accessible to outside researchers, students and companies. The authors propose green zones for open interaction, amber zones for collaboration and red zones for strategic work and argue that most lab work belongs in green and amber.
- Procedure-heavy financial rules. Research institutions follow the General Financial Rules, designed for government purchases in general. The authors say few other countries impose such procedures on scientists and propose freeing proven high-quality institutions from them, with accountability judged by outcomes.
The strongest objection The best argument against this is serious.
These rules exist because public money must be accounted for. Trust in the system is low partly because compliance has often been poor, which is why the rules became strict. Research outcomes are slow and uncertain, so judging them is hard and relaxed rules could invite misuse.
Why the
position still holds That objection is strongest against freeing every institution from every rule. It is much weaker against what is actually proposed: earned autonomy for institutions with a proven record, combined with outcome-based review.
Process rules mainly prove that forms were filled, not that money produced knowledge. Transparent outcome reviews, regular audits and the ability to withdraw autonomy if it is abused protect public funds better than delays at every step.
The authors' arithmetic shows why: a 10% improvement every year compounds to nearly seven times in 20 years. Administrative reform makes that kind of steady improvement possible; more money without it does not.
Quick Facts
Key numbers & takeaways — revise these first
-
K.
-
VijayRaghavan is a former Principal Scientific Adviser to the Government of India and chairs Ashoka University's Science Advisory Council.
-
The General Financial Rules (GFR), 2017 govern procurement and financial transactions of government entities, including publicly funded research laboratories.
-
CRISPR gene-editing technology was developed from the immune defence that bacteria use against viruses called bacteriophages.
-
Much of the early understanding of gene regulation came from studying bacteriophages.
-
The authors propose dividing national laboratories into green (open), amber (collaborative) and red (strategic) zones.
-
India's research and development spending has historically been around 0.65% of GDP.
-
A 10% improvement every year compounds to about 6.7 times in 20 years.
-
The Anusandhan National Research Foundation (ANRF) was set up to promote research and innovation across Indian universities.
Connect the dots for your UPSC preparation.
Standard news covers the event. Log in to read our comprehensive analysis and uncover the hidden constitutional, structural, and ethical dimensions of this topic:
The full logical case for why shorter gaps between discovery and application make administrative speed decisive.
The strongest counter-argument, built at full strength, including the trust and accountability problems behind strict financial rules.
A direct response to that counter-argument, showing where earned autonomy and outcome review protect public money better.
How the green, amber and red zone model for national laboratories would actually work in practice.
Included in this analysis
Join thousands of aspirants analyzing the news deeply.
Unlock Premium — Rs.699 AnnuallyDon't have an account? Sign up for free